Factors of Influence in 2019, Key Indicators and Opportunity within ARRIS International plc, Edwards Lifesciences, DENTSPLY SIRONA, Vail Resorts, Akers Biosciences, and DURECT — New Research Emphasizes Economic Growth

22-02-2019

NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ARRIS International plc (NASDAQ:ARRS), Edwards Lifesciences Corporation (NYSE:EW), DENTSPLY SIRONA Inc. (NASDAQ:XRAY), Vail Resorts, Inc. (NYSE:MTN), Akers Biosciences Inc (NASDAQ:AKER), and DURECT Corporation (NASDAQ:DRRX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ARRS DOWNLOAD: https://Fundamental-Markets.com/register/?so=ARRS
EW DOWNLOAD: https://Fundamental-Markets.com/register/?so=EW
XRAY DOWNLOAD: https://Fundamental-Markets.com/register/?so=XRAY
MTN DOWNLOAD: https://Fundamental-Markets.com/register/?so=MTN
AKER DOWNLOAD: https://Fundamental-Markets.com/register/?so=AKER
DRRX DOWNLOAD: https://Fundamental-Markets.com/register/?so=DRRX

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine ARRIS International plc (NASDAQ:ARRS), Edwards Lifesciences Corporation (NYSE:EW), DENTSPLY SIRONA Inc. (NASDAQ:XRAY), Vail Resorts, Inc. (NYSE:MTN), Akers Biosciences Inc (NASDAQ:AKER), and DURECT Corporation (NASDAQ:DRRX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 20th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ARRIS INTERNATIONAL PLC (ARRS) REPORT OVERVIEW

ARRIS International plc's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, ARRIS International plc reported revenue of $1,651.25MM vs $1,728.52MM (down 4.47%) and analysts estimated basic earnings per share $0.26 vs $0.47 (down 44.68%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, ARRIS International plc reported revenue of $6,614.39MM vs $6,829.12MM (down 3.14%) and analysts estimated basic earnings per share $0.49 vs $0.09 (up 444.44%). Analysts expect earnings to be released on February 27th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.81. The estimated EPS forecast for the next fiscal year is $2.55 and is expected to report on February 27th, 2019.

To read the full ARRIS International plc (ARRS) report, download it here: https://Fundamental-Markets.com/register/?so=ARRS

-----------------------------------------

EDWARDS LIFESCIENCES CORPORATION (EW) REPORT OVERVIEW

Edwards Lifesciences' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Edwards Lifesciences reported revenue of $977.70MM vs $888.50MM (up 10.04%) and analysts estimated basic earnings per share $0.04 vs -$0.01. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Edwards Lifesciences reported revenue of $3,722.80MM vs $3,435.30MM (up 8.37%) and analysts estimated basic earnings per share $3.45 vs $2.77 (up 24.55%). Analysts expect earnings to be released on April 23rd, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $1.22. The estimated EPS forecast for the next fiscal year is $5.84 and is expected to report on January 30th, 2020.

To read the full Edwards Lifesciences Corporation (EW) report, download it here: https://Fundamental-Markets.com/register/?so=EW

-----------------------------------------

DENTSPLY SIRONA INC. (XRAY) REPORT OVERVIEW

DENTSPLY SIRONA's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, DENTSPLY SIRONA reported revenue of $928.40MM vs $1,009.20MM (down 8.01%) and analysts estimated basic earnings per share $0.13 vs $0.39 (down 66.67%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, DENTSPLY SIRONA reported revenue of $3,993.40MM vs $3,745.30MM (up 6.62%) and analysts estimated basic earnings per share -$6.76 vs $1.97. Analysts expect earnings to be released on March 1st, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.82. The estimated EPS forecast for the next fiscal year is $2.17 and is expected to report on March 1st, 2019.

To read the full DENTSPLY SIRONA Inc. (XRAY) report, download it here: https://Fundamental-Markets.com/register/?so=XRAY

-----------------------------------------

VAIL RESORTS, INC. (MTN) REPORT OVERVIEW

Vail Resorts' Recent Financial Performance

For the three months ended October 31st, 2018 vs October 31st, 2017, Vail Resorts reported revenue of $220.00MM vs $220.85MM (down 0.38%) and basic earnings per share -$2.66 vs -$0.71. For the twelve months ended July 31st, 2018 vs July 31st, 2017, Vail Resorts reported revenue of $2,011.55MM vs $1,907.22MM (up 5.47%) and analysts estimated basic earnings per share $9.40 vs $5.36 (up 75.37%). Analysts expect earnings to be released on March 14th, 2019. The report will be for the fiscal period ending January 31st, 2019. The reported EPS for the same quarter last year was $4.12. The estimated EPS forecast for the next fiscal year is $8.05 and is expected to report on September 27th, 2019.

To read the full Vail Resorts, Inc. (MTN) report, download it here: https://Fundamental-Markets.com/register/?so=MTN

-----------------------------------------

AKERS BIOSCIENCES INC (AKER) REPORT OVERVIEW

Akers Biosciences' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Akers Biosciences reported revenue of $0.56MM vs $0.68MM (down 17.56%) and analysts estimated basic earnings per share -$0.26 vs -$1.04. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Akers Biosciences reported revenue of $3.35MM vs $2.96MM (up 13.30%) and analysts estimated basic earnings per share -$6.24 vs -$4.88. Analysts expect earnings to be released on April 2nd, 2019. The report will be for the fiscal period ending December 31st, 2018.

To read the full Akers Biosciences Inc (AKER) report, download it here: https://Fundamental-Markets.com/register/?so=AKER

-----------------------------------------

DURECT CORPORATION (DRRX) REPORT OVERVIEW

DURECT's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, DURECT reported revenue of $8.04MM vs $20.75MM (down 61.26%) and analysts estimated basic earnings per share -$0.02 vs $0.04. For the twelve months ended December 31st, 2017 vs December 31st, 2016, DURECT reported revenue of $49.17MM vs $14.03MM (up 250.59%) and analysts estimated basic earnings per share -$0.03 vs -$0.26. Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.05. The estimated EPS forecast for the next fiscal year is -$0.21 and is expected to report on March 7th, 2019.

To read the full DURECT Corporation (DRRX) report, download it here: https://Fundamental-Markets.com/register/?so=DRRX

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2019 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Latest news
Related news
Related shares
Edwards Lifesciences Corporati
VOL 248,482
173.12 USD
-4.02 / -2.27 %

Durect Corporation
VOL 211,995
0.7455 USD
0.00 / 0.36 %

Vail Resorts Inc
VOL 55,439
219.94 USD
-3.38 / -1.51 %

Akers Biosciences Inc
VOL 33,493
0.7298 USD
-0.02 / -2.69 %

DENTSPLY SIRONA
VOL 2,661,137
54.43 USD
-0.46 / -0.84 %